Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143937 |
| CAS No | NA |
| Mol.F. | C7H13N3O |
| Mol.Wt. | 155.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143938 |
| CAS No | NA |
| Mol.F. | C7H12N4O2 |
| Mol.Wt. | 184.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143939 |
| CAS No | NA |
| Mol.F. | C7H16N2O3 |
| Mol.Wt. | 176.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143940 |
| CAS No | 63884-87-7 |
| Mol.F. | C6H12N2O3 |
| Mol.Wt. | 160.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143941 |
| CAS No | 1932275-09-6 |
| Mol.F. | C5H8N2O4 |
| Mol.Wt. | 160.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143942 |
| CAS No | 26457-81-8 |
| Mol.F. | C6H6N2O |
| Mol.Wt. | 122.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143943 |
| CAS No | 2680539-26-6 |
| Mol.F. | C4H11N3O |
| Mol.Wt. | 117.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143944 |
| CAS No | 69026-93-3 |
| Mol.F. | C12H10N2O2 |
| Mol.Wt. | 214.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143945 |
| CAS No | NA |
| Mol.F. | C12H11N3O2 |
| Mol.Wt. | 229.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143946 |
| CAS No | 550346-46-8 |
| Mol.F. | C5H8N2O4 |
| Mol.Wt. | 160.13 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143947 |
| CAS No | NA |
| Mol.F. | C7H9N3O |
| Mol.Wt. | 151.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143948 |
| CAS No | 6332-00-9 |
| Mol.F. | C7H9N3O |
| Mol.Wt. | 151.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143949 |
| CAS No | NA |
| Mol.F. | H2N4O2 |
| Mol.Wt. | 90.0 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143950 |
| CAS No | NA |
| Mol.F. | C8H16N8O4 |
| Mol.Wt. | 288.27 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143951 |
| CAS No | NA |
| Mol.F. | C8H17N7O3 |
| Mol.Wt. | 259.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143952 |
| CAS No | 42579-28-2 |
| Mol.F. | C3H3N3O3 |
| Mol.Wt. | 129.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |